Eli Lilly hikes Mounjaro prices in the UK
Digest more
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to alternative treatments, like Wegovy. But how do the two weight loss
The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK customers.
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro which launched in the country eight months ago.
Emilly Murray, 35, weighed 22st 1.5lbs and was struggling to squeeze into a size 30 at her heaviest - but has now lost 11 stone and is a size 8
New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs help control diabetes and promote weight loss by altering taste and reducing hunger,
A WOMAN has revealed how she shed weight even after stopping Mounjaro. Arlene Taggart, from the UK, took to social media to share her weight loss transformation which left people stunned.
The survey of 2,000 weight loss patients found that a doubling in price would see 80% coming off Mounjaro, with 51% switching to Wegovy and 29% – around 326,000 people – stopping their weight loss medication altogether.